Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma of the Prostate × Dutasteride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 27 Prostatic Hyperplasia 5 Neoplasms 4 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Lower Urinary Tract Symptoms 1 Erectile Dysfunction 1 Adenocarcinoma of the Prostate 1

Interventions

sipuleucel-T 1 pazopanib 1 enzalutamide 1 Watchful Waiting 1 STA 9090 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Radiosurgery 1 Dutasteride 1 Androgen Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01368003 2015-09-01

STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling

Dana-Farber Cancer Institute

Phase 2 Withdrawn

Adenocarcinoma of the Prostate

Data powered by HemOnc (CC BY 4.0) Colophon ⚡